no weight loss with tirzepatide Can Help You Lose Weight? Tirzepatide for Medical Weight Loss

Adults aged 45 and overmany of whom are beginning to feel the wear and tear of long workdays, sedentary lifestyles, or sports-related injuriesare entering a phase of life where nerve sensitivity, tingling, and radiating back and leg discomfort become more common

Highly recommend!John SimoneMay 19, 2025I have had a long journey with myself wellness and their staff

Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

How PlexusDx Supports a More Personalized Approach PlexusDx Precision Peptide Genetic Test reveals genetic predispositions in antioxidant metabolic pathwaysincluding variants in glutathione synthesis and detoxification genesthat may help provide context for your glutathione timing and dosing needs

Key Research Findings: In early studies, Retatrutide has demonstrated significant body weight reduction, in part due to increased thermogenesis and lipolysis (Abouelmagd & Abdelrehim